What marijuana reclassification could mean for medical research
Added on 17 May 2024
The U.S. pot sector could see an influx of medical research funding from healthcare investors amid renewed interest from pharmaceutical firms, should a proposal to reclassify cannabis as a lower-risk substance be approved, industry experts said.
Image by jcomp on Freepik
More news
